# Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure

> **NCT01968395** · PHASE4 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Bacterial Infections and Mycoses
- Liver Disease

## Interventions

- **DRUG:** Caspofungin 70 mg

## Key facts

- **NCT ID:** NCT01968395
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-08
- **Final completion:** 2014-10-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968395, "Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01968395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*